THE IMPACT OF COMPLIANCE WITH BIOLOGIC THERAPY ON CLINICAL OUTCOMES IN PATIENTS WITH RHEUMATOID ARTHRITIS

被引：0
|
作者：
Tang, B. [1 ]
McKenzie, R. S. [1 ]
Freedman, D. [2 ]
Wagner, S. [2 ]
Piech, C. T. [1 ]
机构：
[1] Centocor Ortho Biotech Serv LLC, Horsham, PA USA
[2] Consumer Hlth Sci Int, Princeton, NJ USA
来源：
VALUE IN HEALTH | 2009年 / 12卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)73140-5
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A16 / A16
页数：1
相关论文
共 50 条
  • [21] Malignancy and biologic therapy in rheumatoid arthritis
    Askling, Johan
    Bongartz, Tim
    CURRENT OPINION IN RHEUMATOLOGY, 2008, 20 (03) : 334 - 339
  • [22] Rheumatoid arthritis and the era of biologic therapy
    Anshuman P. Malaviya
    Andrew J. K. Östör
    Inflammopharmacology, 2012, 20 (2) : 59 - 69
  • [23] IS THE METABOLIC SYNDROME IN RHEUMATOID ARTHRITIS PATIENTS INFLUENCED BY THE BIOLOGIC THERAPY?
    Nemes, D.
    Amaricai, E.
    Catan, L.
    Dragoi, M.
    Popa, D.
    Puenea, G.
    Andrei, D.
    Balacescu, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 410 - 410
  • [24] Choice of Biologic Therapy for Patients with Rheumatoid Arthritis: The Infection Perspective
    De Keyser, Filip
    CURRENT RHEUMATOLOGY REVIEWS, 2011, 7 (01) : 77 - 87
  • [25] Integrating biologic therapy into the comprehensive care of patients with rheumatoid arthritis
    Lipsky, PE
    JOURNAL OF RHEUMATOLOGY, 2005, 32 : 54 - 57
  • [26] CHARACTERISTICS OF PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH BIOLOGIC THERAPY AS MONOTHERAPY
    Gomez-Centeno, A.
    Martinez, O.
    Ballina, F.
    Rodriguez, J.
    Grana, J.
    Brito, M.
    Sampedro, J.
    Iglesias, G.
    Delgado, C.
    Monteagudo, I.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 490 - 490
  • [27] THE ROLE OF CORTICOSTEROIDS IN RHEUMATOID ARTHRITIS PATIENTS UNDER BIOLOGIC THERAPY
    Madureira, P. S.
    Pimenta, S.
    Vieira, R.
    Fonseca, R.
    Goncalves, D. R.
    Aguiar, F.
    Rocha, T.
    Bernardo, A.
    Bernardes, M.
    Costa, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 1067 - 1067
  • [28] THE IMPACT OF AGE ON DISCONTINUATION OF BIOLOGIC DMARDs IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Rivera Teran, V.
    Sicsik, S.
    Vega-Morales, D.
    Irazoque-Palazuelos, F.
    Miranda, D.
    Casasola, J. C.
    Carrilo, S.
    Pena, A.
    Castillo Ortiz, A.
    Munoz-Monroy, O. E.
    Duran Barragan, S.
    Paz, A.
    Torres Valdez, E.
    Valdes Corona, L. F.
    Xibille Friedmann, D. X.
    Zamora, E.
    Ramos, A.
    Santana, N.
    Vazquez, M.
    Guerrero, F.
    Zepeda, C.
    Alvarado, K.
    Rivera, M.
    Alpizar-Rodriguez, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 559 - 560
  • [29] Patient Adherence with Biologic Therapy in Rheumatoid Arthritis: A Real-World Review of Compliance
    Chanroux, Laurent
    Mboge, Fara
    Baldock, Denise
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [30] Generalizability of Patients With Rheumatoid Arthritis in Biologic Agent Clinical Trials
    Vashisht, Priyanka
    Sayles, Harlan
    Cannella, Amy C.
    Mikuls, Ted R.
    Michaud, Kaleb
    ARTHRITIS CARE & RESEARCH, 2016, 68 (10) : 1478 - 1488
12345